Source linked

ANDI تحول العلماء العامين إلى متخصصين في الأوبليبيا

ثلاثة من كل 100 طفلا يعانيون من الحمض النووي، ولكن معظم المتخصصين في العينات الطفيلية يعيشون في قليلة من الدول.

andipedignihdeveloper toolspediatric eye care

Three in every 100 children in the U.S. have amblyopia, yet most pediatric eye specialists cluster in a handful of states.

What ANDI Does

ANDI, short for Amblyopia Navigator Decision‑Support Instrument, is a browser‑based tool that turns any eye doctor into an amblyopia specialist. It distills 147 peer‑reviewed studies into a step‑by‑step workflow that covers diagnosis, glasses prescription, patching, atropine drops, and newer digital games or videos. Clinicians without pediatric training can use the same evidence‑based algorithm that PEDIG investigators rely on.

How It Works

After a quick data entry—age, visual acuity, refractive error, and eye alignment—ANDI calculates the optimal glasses prescription and monitors whether glasses alone will suffice for up to a third of patients. If improvement stalls, the tool walks the user through patching schedules, atropine dosing, or digital therapy options, and advises when to intensify treatment, switch modalities, or refer to a specialist. Follow‑up intervals and red‑flag signs for recurrence are also generated. The entire process can be completed at the initial visit or any subsequent appointment.

Offline users can download the article figures as printable reference sheets, ensuring that even clinics without reliable internet still benefit from the guidance.

Impact on Care Delivery

PEDIG, an NIH‑funded network of over 400 investigators, built ANDI to address the geographic disparity in pediatric eye care. By making evidence‑based decision support available to generalists, the tool reduces the need for specialist referrals in underserved regions. Early detection and treatment remain critical—amblyopia can be reversed in childhood, but untreated cases lock in permanent vision loss that affects school performance, employment, and overall quality of life.

ANDI is freely accessible at https://public.jaeb.org/pedig and was published May 7 2026 in JAMA Ophthalmology (DOI: 10.1001/jamaophthalmol.2026.1095). Its deployment marks a concrete step toward closing the access gap for children with amblyopia across the United States.


Source: NIH-supported project expands access to care for children with amblyopia
Domain: nih.gov

Read original source ->

External source stays available while the OJO article and comment thread stay local.

Comments load interactively on the live page.